SCHEMBL4966285

SCHEMBL4966285

CC(=O)c1cccc(NC(=O)NCCc2ccccc2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.79
MEN1 O00255 7/20 0.69
MAPT P10636 5/20 0.69
NPC1 O15118 2/20 0.69
RAB9A P51151 2/20 0.69
LMNA P02545 4/20 0.64
HTT P42858 3/20 0.64
ALDH1A1 P00352 2/20 0.64
CA12 O43570 1/20 0.63
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA9 Q16790 1/20 0.63
SMN1; SMN2 Q16637 2/20 0.59
TP53 P04637 1/20 0.59
EPHX1 P07099 2/20 0.58
KDM4E B2RXH2 1/20 0.58
TSHR P16473 1/20 0.58
CNR1 P21554 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC2 Q92769 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19472659 0.89 KMT2A (0.79) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL19472777 0.89 KMT2A (0.79) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL4912471 0.88 KMT2A (1.00) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL10192070 0.84 KMT2A (0.82) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL4606056 0.83 EPHX1 (0.81) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL8130235 0.83 RAB9A (0.67) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL22588919 0.83 KMT2A (0.72) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL2827311 0.83 KMT2A (0.72) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL29956830 0.83 MAPT (0.67) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL25722908 0.82 MAPT (0.75) KMT2AMEN1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1969051-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. Organon (NL) 2008-09-17 EP disclosed
WO-2008024139-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. ORGANON (NL) 2008-02-28 WO disclosed
WO-2007079180-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. ORGANON (NL) 2007-07-12 WO disclosed
US-20070155747-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE KADMUS PHARMACEUTICALS, INC. (US) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155747-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ABHD6 KMT2A 2252/4885MEN1 4781/4885MAPT 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.